ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

In Brief: LYNNE PENBERTHY Was Named Associate Director For Surveillance Research In NCI’s Division of Cancer Control and Population Sciences

November 8, 2013

DCE Advisors OK Concepts for Registry, Grants In Breast Cancer

June 25, 1993

Also in this 8-page issue: NIH opens 240-bed Hatfield Clinical Research Center.

September 24, 2004

New Predictive Score May Help In Planning Adjuvant Therapy

September 26, 2008

FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.

June 30, 2000